Emerging kinase inhibitors of the treatment of gastric cancer.
about
The Human Cathelicidin Antimicrobial Peptide LL-37 and Mimics are Potential Anticancer DrugsmiR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.Antitumor activity of TY-011 against gastric cancer by inhibiting Aurora A, Aurora B and VEGFR2 kinases.Di-2-pyridylhydrazone Dithiocarbamate Butyric Acid Ester Exerted Its Proliferative Inhibition against Gastric Cell via ROS-Mediated Apoptosis and Autophagy.
P2860
Emerging kinase inhibitors of the treatment of gastric cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Emerging kinase inhibitors of the treatment of gastric cancer.
@en
type
label
Emerging kinase inhibitors of the treatment of gastric cancer.
@en
prefLabel
Emerging kinase inhibitors of the treatment of gastric cancer.
@en
P2093
P2860
P50
P1476
Emerging kinase inhibitors of the treatment of gastric cancer.
@en
P2093
Eleonora Marrucci
Marco Imperatori
Marianna Silletta
P2860
P304
P356
10.1517/14728214.2015.1051467
P407
P577
2015-05-28T00:00:00Z